Our Team

Avail is run by leaders who know how to create and scale novel Medtech solutions.

Our Leadership

Daniel Hawkins

CEO

Daniel has over twenty-five years experience in executive management, marketing, product management and business development roles in both large and emerging medical device companies including Advanced Cardiovascular Systems, Inc. (ABT), Endologix (ELGX), Restore Medical (MDT) and EnteroMedics (ETRM) and Intuitive Surgical (ISRG). He is a Co-founder of Calibra Medical (JNJ) and Founder/CEO of Shockwave Medical (SWAV) where he led the company from concept to multiple regulatory approvals, built the company to 96 people, initiated commercialization in multiple countries and successfully raised over $100M. Daniel holds an MBA from Stanford, a B.S. in Economics from Wharton and is a named inventor on over 140 patents and applications including the foundational patents for both Calibra Medical and Shockwave Medical. In 2017, Daniel was honored by Goldman Sachs as one of its Top 100 Most Intriguing Entrepreneurs.

Steve Morgan

CFO

Steve has over twenty-five years of experience as a senior financial executive responsible for managing all aspects of finance, legal and human resources for privately and publicly held companies. Steve has built businesses from the ground up as well as helped to scale existing companies to the next level. Before joining Avail, Steve was the CFO at several venture-backed technology companies including Panzura, Cyphort, Edgewater Networks, Fanfare, RouteScience Technologies and Atmosphere Networks. Prior to Atmosphere, Steve held a number of finance positions at Whitetree, Integrated Process Equipment Corporation and KPMG. During his career, Steve has raised over $150 million in equity and debt from top tier investors, guided several companies to successful exits, and established strong financial infrastructure to help grow and expand companies. Steve earned his bachelor's degree in business with a concentration in accounting from California Polytechnic State University in San Luis Obispo.

Ravi Kalluri

VP, Engineering

Ravi brings over twenty-two years of global product development experience in both startups as well as Fortune 50 companies. Prior to joining Avail, he held senior leadership roles at Reliance Jio (Reliance.NS), Verizon (VZ) and Intel (INTC). He was also a member of the founding team at Bluejeans Network where he helped build and scale the global Video Conferencing platform. Prior to Bluejeans, Ravi held technical leadership roles developing conferencing platforms and products at British Telecom (BT) and Polycom (PLT). He holds a M.S. in Electrical and Computer Engineering from University of Nevada, Las Vegas, a B.E. in Electronics and Communications Engineering from Gulbarga University and is an inventor of multiple patents in Video Conferencing, Streaming Media, Voice Search and Cloud DVR areas.

Jerry Carter

VP, Sales

Jerry has over twenty-six years of experience in sales, sales management, strategic sales and IDN corporate contracting. Throughout his career he has launched and sold new products and solutions across the entire spectrum of the cardiovascular service line including C.R. Bard’s (BCR) Interventional Cardiology and Electrophysiology divisions, Arterial Vascular Engineering’s entrance into the coronary stent market, and the entire portfolio of Medtronic’s (MDT) Cardiovascular Group’s product launches over the last 8 years. Jerry holds a B.S. in Finance from University of Nevada, Las Vegas and an MBA from Arizona State University.

Jack Germanson

VP, Field Operations

Jack has over twenty-five years of dynamic global expertise, including a depth of technical and general management leadership experience at Medtronic (MDT). He has an impressive track record of building high performing teams and is known for his relentless focus on improving patient outcomes and delivering exceptional customer experience. From software-based solutions and implementations to innovative medical devices, Jack has led from concept to successful commercialization. He holds a M.S. in Management of Technology from University of Minnesota as well as B.S. in Mechanical Engineering from University of Wisconsin.

Amanda Bloom

VP, Product

Amanda has over 15 years of Product Management and Product Marketing experience in smaller organizations as well as Fortune 500 companies. Her career experience has focused around the cross-functional development and launches of disruptive technologies within the Orthopedic, Neurosurgical, and Spine spaces. Prior to joining Avail, Amanda held marketing leadership roles with Zimmer Biomet's (ZBH) Robotics Division managing their Spine and Neurosurgical Robotics, Data Technology and Solutions pipeline and suite of products. Prior to her time at Zimmer Biomet, Amanda held various roles at NuVasive, Inc. (NUVA), managing their flagship portfolio, and oversaw the development of a number of new procedures and technologies. Amanda began her career with Johnson and Johnson (JNJ) and has a passion for improving the healthcare landscape by delivering innovative technologies that ultimately improve patient outcomes, and streamlining the delivery of care for providers. Amanda holds a B.S. in Biopsychology from Tufts, University.

Our Board

Daniel Hawkins

Daniel has over twenty-five years experience in executive management, marketing, product management and business development roles in both large and emerging medical device companies including Advanced Cardiovascular Systems, Inc. (ABT), Endologix (ELGX), Restore Medical (MDT) and EnteroMedics (ETRM) and Intuitive Surgical (ISRG). He is a Co-founder of Calibra Medical (JNJ) and Founder/CEO of Shockwave Medical (SWAV) where he led the company from concept to multiple regulatory approvals, built the company to 96 people, initiated commercialization in multiple countries and successfully raised over $100M. Daniel holds an MBA from Stanford, a B.S. in Economics from Wharton and is a named inventor on over 140 patents and applications including the foundational patents for both Calibra Medical and Shockwave Medical. In 2017, Daniel was honored by Goldman Sachs as one of its Top 100 Most Intriguing Entrepreneurs.

Peter Hebert

Peter co-founded Lux Capital with the idea that in order to have the biggest impact on the future, one should support the most scientifically and technologically ambitious ventures. Peter led Lux’s investments in Auris Health (acquired by Johnson & Johnson (JNJ) for up to $6.05 billion, making it one of top 10 VC-backed private M&A transactions of all-time), Lux Research (acquired by Private Equity), Luxtera (acquired by Cisco (CSCO) for $660 million), and SiBEAM (acquired by Silicon Image (SIMG)). Current investments include Avail, Bright Machines, Everspin Technologies (MRAM), Flex Logix, Halo Neuroscience, Matterport, Ripcord, Transphorm, and Vium. In 2003, Peter led the spin-off of Lux Research. As its founding CEO, he helped build Lux Research into the leading emerging-technology research firm. Peter began his career at Lehman Brothers, where he worked in the firm’s top-ranked Equity Research group. He was a Chancellor’s Scholar and graduated cum laude from Syracuse University’s Newhouse School, and was the Founding President of its first venture organization, Future Business Leaders and Entrepreneurs. He has been a guest on CNBC and Bloomberg TV, and speaker at Columbia, Cornell, MIT, Stanford, Yale, and the National Science Foundation.

Fred Moll, M.D.

Frederic H. Moll, M.D. is the Chief Development Officer for Johnson & Johnson (JNJ) Medical Devices Companies. Dr. Moll co-founded Auris where he served as its CEO before it was acquired by Johnson & Johnson. Prior to Auris, Dr. Moll was a founder of three public companies; Hansen Medical (HNSN), Restoration Robotics (HAIR) and Intuitive Surgical (ISRG). Prior to Intuitive, he served as a founder and medical director of Origin Medsystems, acquired by Eli Lily (LLY), and Endotherapeutics, acquired by United States Surgical. Dr. Moll is a distinguished and prolific medical device entrepreneur and has more than 20 years of medical device and high technology experience. He holds an MD from the University of Washington School of Medicine, an MS degree in Management from Stanford University’s Sloan Program and a B.A. degree from the University of California at Berkeley.

Jay Watkins

Jay has extensive experience founding and funding healthcare companies. He is a Managing Director with De Novo Ventures and serves as a Lecturer in Management at the Stanford Graduate School of Business and Co-Director of the graduate class in Biodesign Innovation. He was founding CEO of Origin Medsystems, a venture funded medical technology start-up acquired by Eli Lilly & Company (LLY). After Lilly formed Guidant, he joined the Management Committee and served as President of several divisions, including the Minimally-Invasive Surgery Group and Heart Rhythm Technologies. He also co-founded Gynecare, which went public and was later acquired by Johnson & Johnson (JNJ). At Guidant, Jay formed and led Compass, Guidant’s corporate business development and new ventures group, where he was directly involved in the acquisition of two public companies and led venture investments in fourteen companies including Impella (acquired by Abiomed (ABMD)) and Intuitive Surgical (ISRG). Prior to founding Origin, Jay held management positions in several start-ups, including Microgenics Corporation (acquired by Boehringer Mannheim), and was a consultant with McKinsey & Company (MTRX). He has served as a board member for both private and public MedTech companies and has been an active advisor and faculty member for the Kauffman Labs program that is dedicated to educating and training founders. Jay holds an MBA from Harvard Business School and an undergraduate degree from Stanford University.

Join the Team

Make a difference. We’re looking for talented,
driven individuals to join our collaborative
and innovative environment.